Bachem to showcase Tides leadership at Summer 2024 events

Bubendorf, Switzerland: – Peptide and Oligonucleotide technology specialist Bachem AG will be represented at three influential biopharma events during July and August 2024 in Asia and Europe.

At all three, Bachem will highlight its advanced development and manufacturing capabilities as a leading partner for tides in therapeutic applications and research.

Bio Asia Taiwan

From July 24, Bachem will participate in the five-day Bio Asia-Taiwan 2024 networking conference that brings together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia to explore business opportunities with Taiwan’s emerging biotech sector.

Bachem will be represented by its Manager Business Development Sales Asia, Dawson Chen, at the conference, hosted in Halls 1 & 2 of the Taipei Nangang Exhibition Center, in the Taiwanese capital.

Peptide Therapeutics Forum Basel

During August 2024, Bachem will attend two important European events, starting with the Peptide Therapeutics Forum in Basel, near its own headquarters at Bubendorf, Switzerland.

This three-day scientific conference, opening August 22 at Basel’s Biozentrum event center, is part of the Basel Life franchise of innovative platforms dedicated to exchange of knowledge on various aspects of drug development.

With this event, the focus is on peptides, with presentations highlighting important new insights on peptide applications in drug discovery, and latest tide-based development candidates, along with latest trends and developments from the field of therapeutic peptides.

Bachem is a Gold Sponsor of the forum and is also one of the select group of exhibitors, with a stand highlighting its highly advanced  peptide manufacturing capabilities as well as its extensive catalog of products.

The Bachem team at the Basel forum will include Director Business Development Riccardo Bernasconi, Senior Business Development Manager Bernd Raschack, and Global Head Recruitment Martin Geissman.

EPS Florence

Two days after the Basel conference closes, Bachem will be appearing in Firenze (Florence) at the 37th European Peptide Symposium and 14th International Peptide Symposium, a five-day dual event opening August 25 at the historic city’s Palazzo dei Congressi.

These global peptide symposia examine all relevant aspects of peptide science: from new synthetic methods to emerging technologies, including structural and conformational studies, with focus on material, biological, and therapeutic applications.

Bachem is again a sponsor of the event and will participate as an exhibitor and contributor to the scientific program, which features oral presentations from established and emerging scientists, with special attention to young investigators, as well as posters.

The Bachem team at EPS 2024 will include Head of Global Research Chemicals & Specialties Gilles Parmentier and Group Leader Research Chemical Sales Stephane Lefevre.

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

For further information, see www.bachem.com

Resources

Click on Bachem at Bio Asia Taiwan 2024 for further information.
Click on Bachem at Peptide Therapeutics Forum Basel 2024 for further information.
Click on Bachem at EPS Florence 2024 for further information.
Click on Bachem Leading partner for tides  to learn more.
Click on Bachems News to see latest News & Events.